Recent healthcare polices, such as the Center for Medicare and Medicaid Services (CMS) SEP-1, have not focused on the impact of non-ventilator-associated hospital-acquired infections (NV-HAP) on sepsis rates. With a 36.3% sepsis rate in NV-HAP patients compared to 1.9% in those with community-acquired pneumonia, NV-HAP sees staggering 19-fold increase in sepsis incidence.
Meanwhile, sepsis treatment in the U.S. costs the industry $24 billion annually, so more proactive steps toward prevention could not only mean healthier patients, but better financial outcomes as well.
101 Creekside Crossing, Suite 1700-735, Brentwood, Tennessee, 37027 All rights reserved | Privacy Policy
You are receiving this message at newsletter@newslettercollector.com on behalf of PSQH. If you prefer not to receive future messages like this about PSQH products and services, please unsubscribe here. Your request will be processed within 10 days, as required by law. You may receive additional promotions within that time. If you would like to make changes to your subscriptions and mailing preferences, please visit our Preference Center.
